# Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1

> **NCT01994486** · PHASE2 · COMPLETED · sponsor: **University of Florida** · enrollment: 20 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

- **DRUG:** Telaprevir and Sofosbuvir

## Key facts

- **NCT ID:** NCT01994486
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-04
- **Final completion:** 2014-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01994486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01994486, "Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01994486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*